Cancer

INDICATION: Lymphoma; breast cancer; colorectal cancer

Mouse studies suggest intratumoral injection of a TLR9 agonist and an agonist antibody against OX40 could help treat lymphoma, breast cancer and colorectal cancer. In a mouse model of

Read the full 344 word article

User Sign In